Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Herman Day Suit, D.Phil., M.D.


This page shows the publications co-authored by Herman Suit and Harald Paganetti.
Connection Strength

  1. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol. 2008 Feb; 86(2):148-53.
    View in: PubMed
    Score: 0.373
  2. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res. 2007 Jan; 167(1):12-42.
    View in: PubMed
    Score: 0.346
  3. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002 Jun 01; 53(2):407-21.
    View in: PubMed
    Score: 0.252
  4. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital. Radiat Res. 2015 Feb; 183(2):174-87.
    View in: PubMed
    Score: 0.151
  5. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 2010 Apr; 95(1):3-22.
    View in: PubMed
    Score: 0.108
  6. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol. 2005 Sep 21; 50(18):4337-53.
    View in: PubMed
    Score: 0.079
  7. Proton beams to replace photon beams in radical dose treatments. Acta Oncol. 2003; 42(8):800-8.
    View in: PubMed
    Score: 0.066
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.